Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

China · Delayed Price · Currency is CNY

19.37

-0.13 (-0.67%)

Oct 30, 2026, 3:04 PM CST

Market Cap	21.77B +21.0%
Revenue (ttm)	8.85B -15.6%
Net Income	804.08M -6.7%
EPS	0.70 -6.5%
Shares Out	1.12B
PE Ratio	27.80
Forward PE	13.84
Dividend	0.28 (1.44%)
Ex-Dividend Date	Oct 8, 2026

Volume	18,549,500
Open	19.53
Previous Close	19.50
Day's Range	18.71 - 20.16
52-Week Range	14.92 - 28.50
Beta	0.26
Analysts	Strong Buy
Price Target	26.67 (+37.69%)
Earnings Date	Oct 23, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects;... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1989

Employees 6,787

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000739

Full Company Profile

Financial Performance

In 2025, SHE:000739's revenue was 9.78 billion, a decrease of -18.62% compared to the previous year's 12.02 billion. Earnings were 890.68 million, a decrease of -13.62%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 000739 stock is "Strong Buy." The 12-month stock price target is ¥26.67, which is an increase of 37.69% from the latest price.

Price Target

¥26.67

(37.69% upside)

Analyst Consensus: Strong Buy

Stock Forecasts